GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
KLCCX
Price
$9.23
Change
-$0.49 (-5.04%)
Updated
Apr 3 closing price
Net Assets
1.15B
Ad is loading...

GFACX vs KLCCX

Header iconGFACX vs KLCCX Comparison
Open Charts GFACX vs KLCCXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
Federated Hermes Kaufmann Large Cap C
Price$9.23
Change-$0.49 (-5.04%)
VolumeN/A
Net Assets1.15B
GFACX vs KLCCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. KLCCX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and KLCCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. KLCCX (1.15B). GFACX (0.00) and KLCCX (0.00) have matching dividends . GFACX was incepted earlier than KLCCX: GFACX (24 years) vs KLCCX (17 years). KLCCX (1.96) is less costly to investors than GFACX (1.36). GFACX is a more actively managed with annual turnover of: 25.00 vs. KLCCX (18.00). GFACX has a lower initial minimum investment than KLCCX: GFACX (250) vs KLCCX (1500). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. KLCCX (-34.90). GFACX return over 5 years is better than : 59.73 vs. KLCCX (-51.93).
GFACXKLCCXGFACX / KLCCX
Total Expense Ratio1.361.8972%
Annual Report Gross Expense Ratio1.361.9669%
Fund Existence24 years17 years-
Gain YTD-5.003-7.42967%
Front LoadN/AN/A-
Min. Initial Investment250150017%
Min. Initial Investment IRAN/AN/A-
Net Assets280B1.15B24,306%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.75-34.905%
Returns for 3 years0.63-62.34-1%
Returns for 5 years59.73-51.93-115%
Returns for 10 years44.46-47.15-94%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences